Evanston Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Evanston Advisors's PFE Position: Q4 2018 in Review
Evanston Advisors sold out of Pfizer (PFE) in Q4 2018, closing a stake of 5,733 shares — an estimated $240K sold.
Evanston Advisors first reported a position in PFE in Q2 2013 and held it in 16 quarters. The position peaked at $6.91M in Q2 2016. 2,403 funds tracked by Wall St. Rank hold PFE as of Q4 2018.
- Evanston Advisors reported no remaining Pfizer position as of Q4 2018 after selling out during the quarter.
- Evanston Advisors sold 5,733 Pfizer shares in Q4 2018, an estimated $240K.
- Evanston Advisors first reported a position in Pfizer in Q2 2013 and held it in 16 quarters.
- Evanston Advisors's Pfizer position peaked at $6.91M in Q2 2016.
- 2,403 funds tracked by Wall St. Rank held Pfizer as of Q4 2018.
Based on Evanston Advisors's 13F filing for Q4 2018, filed 11 Feb 2019.